Neoadjuvant chemotherapy for early breast cancer - Author's reply

Lancet Oncol. 2018 Mar;19(3):e130. doi: 10.1016/S1470-2045(18)30120-7.

Authors

Paul McGale¹, David Dodwell², Carolyn Taylor², Richard Gray²; Early Breast Cancer Trialists' Collaborative Group

Affiliations

¹ EBCTCG Secretariat, Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, Oxford OX3 7LF, UK. Electronic address: bc.overview@ndph.ox.ac.uk.
² EBCTCG Secretariat, Medical Research Council Population Health Research Unit, Nuffield Department of Population Health, Oxford OX3 7LF, UK.

PMID: 29508755
DOI: 10.1016/S1470-2045(18)30120-7

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms*
Chemotherapy, Adjuvant
Humans
Neoadjuvant Therapy*

Grants and funding